Biology and medicines are undergoing a renaissance - previously limited to small molecules and biologics - now RNA/DNA/cells as well as software have become therapeutics.

​

Digital technology and sensors are ubiquitous, bringing tremendous scale and computing speed.

​

RNA, DNA, cells, and synthetic biologic systems can be programmed to target and modulate cellular machinery.

Bio and tech are converging: software is becoming medicine and medicine is becoming software.

​

“bio+ tech” are enabling new classes of medicines, novel models of care, and delivery.